CLINICAL_TRIALS
trial_result
· 2012-05-09
Clinical Trial Update: Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD) [Phase 4]
Summary
Phase 4 trial update evaluating cognitive-behavioral therapy combined with escitalopram for Generalized Anxiety Disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Generalized Anxiety Disorder | Phase 4 | Status: COMPLETED | Results posted: 2012-05-09